ConductScience.org, home

Paper40938239

Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis.

Milani P and 22 others. JACC CardioOncol, 2025. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis. Papers, record 40938239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40938239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis.
PubMed
Journal
JACC CardioOncol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
2.87, provisional
iCite
Revised in PubMed
2026-01-17
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Milani PPaolo
2Sanna GDGiuseppe Damiano
3Bellofiore CClaudia
4Nuvolone MMario
5Basset MMarco
6Mussinelli RRoberta
7Mazzini GGiulia
8Nanci MMartina
9Ciardo MMartina
10Caminito SSerena
11Ghazi Esfahani MMatin
12Sadrzadeh MMohammadjavad
13Fogliani AAlessandro
14Benigna FFrancesca
15Guida GGianluigi
16Salinaro FFrancesco
17Bosoni TTiziana
18Barassi AAlessandra
19Foli AAndrea
20Albertini RRiccardo

Source PubMed

See all 23 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119520758Screening panels for detection of monoclonal gammopathies.Clin Chem2009https://conductscience.org/library/papers/19520758PubMed
227585505Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System.J Am Coll Cardiol2016https://conductscience.org/library/papers/27585505PubMed
328550043AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis.Blood2017https://conductscience.org/library/papers/28550043PubMed
432130406Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis.Blood Adv2020https://conductscience.org/library/papers/32130406PubMed
525044787Online registry for mutations in hereditary amyloidosis including nomenclature recommendations.Hum Mutat2014https://conductscience.org/library/papers/25044787PubMed
625115890A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.Blood2014https://conductscience.org/library/papers/25115890PubMed
736621346Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM Criteria.Clin Lymphoma Myeloma Leuk2023https://conductscience.org/library/papers/36621346PubMed
834001889
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies.
Blood Cancer J2021https://conductscience.org/library/papers/34001889PubMed
912194920Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.Clin Chem2002https://conductscience.org/library/papers/12194920PubMed
1038989681Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis.Amyloid2024https://conductscience.org/library/papers/38989681PubMed
1131109193Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.Circulation2019https://conductscience.org/library/papers/31109193PubMed
1221917755Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue.Blood2012https://conductscience.org/library/papers/21917755PubMed
1315131802Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families.Gastroenterology2004https://conductscience.org/library/papers/15131802PubMed
1428439985The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.Am J Hematol2017https://conductscience.org/library/papers/28439985PubMed
1528343171Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays.Clin Chem Lab Med2017https://conductscience.org/library/papers/28343171PubMed
1611274017Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.Clin Chem2001https://conductscience.org/library/papers/11274017PubMed
1727143678Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.Circulation2016https://conductscience.org/library/papers/27143678PubMed
1835567705Endomyocardial biopsy in the clinical context: current indications and challenging scenarios.Heart Fail Rev2023https://conductscience.org/library/papers/35567705PubMed
1923091105New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.J Clin Oncol2012https://conductscience.org/library/papers/23091105PubMed
2036028388Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging.Am J Cardiol2022https://conductscience.org/library/papers/36028388PubMed

See all 47 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42536398The light chain hunt: appraising assays in AL amyloidosis.Blood Adv2026https://conductscience.org/library/papers/42536398PubMed
42397016Light Chain Monoclonal Gammopathy of Undetermined Significance: Diagnosis, Biology, and Clinical Management.Eur J Haematol2026https://conductscience.org/library/papers/42397016PubMed
42305910Unveiling the unseen: navigating heart involvement in amyloidosis with biomarkers beyond the horizons of imaging.Eur Heart J Imaging Methods Pract2026https://conductscience.org/library/papers/42305910PubMed
41995733Global validation of revised sFLC cutoffs in amyloidosis.Blood Adv2026https://conductscience.org/library/papers/41995733PubMed
41955068Monoclonal gammopathy exclusion in transthyretin amyloid cardiomyopathy: iStopMM estimated glomerular filtration rate-adjusted serum-free light chain ratio cut-offs.Eur Heart J2026https://conductscience.org/library/papers/41955068PubMed
41705764Reply: Refining Free Light Chain Ratio in Systemic Amyloidosis.JACC CardioOncol2026https://conductscience.org/library/papers/41705764PubMed
41705763Refining Free Light Chain Ratio in Systemic Amyloidosis.JACC CardioOncol2026https://conductscience.org/library/papers/41705763PubMed
41130643The FLC Ratio Reframed: Averting Unnecessary Heart Biopsies in Wild-Type ATTR Amyloidosis.JACC CardioOncol2025https://conductscience.org/library/papers/41130643PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40938239

GET https://conductscience.org/api/papers/v1/40938239/authors?page=2